BioSpace News Archive

PharmAbcine Inc. (KOSDAQ: 208340ks) entered into a Materials Cooperative Research and Development Agreement (MCRADA) with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), in which NIAID will assess the efficacy of PMC-403, a novel Tie2-activating antibody with a unique mode of action, for the treatment of Systemic Capillary Leak Syndrome (SCLS, Clarkson Disease).

Aatru Medical, LLC (“Aatru”) announced today that its technical Abstract has been accepted for presentation at both the SAWC/WHS 2020 conference in North Carolina and also at EWMA 2020, to be held in London, England.

Central Texas Pain Center is pleased to announce that Dr. Gregory Yanez has joined their team of highly talented interventional pain doctors to provide high-quality, care to patients in the South Austin community.

Genosity Inc., announced today that it has received CLIA approval for its tumor exome and liquid biopsy cancer monitoring platform, AsTra (Assessment and Tracking), designed to identify a patient’s unique tumor molecular profile that can be used for ongoing, personalized Minimal Residual Disease (MRD) monitoring.

SQI Diagnostics, Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced that the Company’s board of directors has appointed Robert L. Chioini as Chief Executive Officer

Therapure Biomanufacturing, a division of Therapure Biopharma Inc., announced today the signing of an agreement with VBI Vaccines Inc. for the manufacture of their coronavirus vaccine candidates

SkyWater Technology, the trusted technology realization partner, announced the DARPA Three Dimensional Monolithic System-on-a-Chip (3DSoC) program, in collaboration with Massachusetts Institute of Technology (MIT), has entered its second phase

The World’s Leading Non-profit Organization in Prostate Cancer Research Encourages Americans to Eat Healthier While Raising Awareness About Health Disparities Among African American Men

IlluminOss Medical, a medical device company focused on minimally invasive orthopedic fracture repair, today announced that it has received expanded U.S. Food and Drug Administration (FDA 510k) clearance for its Photodynamic Bone Stabilization System for treatment of fractures of the fibula.

Blue Cross Blue Shield of Massachusetts (Blue Cross) has earned an “Excellent” accreditation rating from NCQA (1) for its clinical quality, member experience and performance against operational standards for Commercial HMO/POS and PPO plans, marking the fourth consecutive